Results 121 to 130 of about 2,471,270 (185)

Phage therapy for recurrent urinary tract infections: A qualitative study using the theoretical framework of acceptability. [PDF]

PLoS One
Wenzel D, Crick M, Tarrant C, Revitt O, Senior J, Haines M.   +5 more
europepmc   +1 more source

Phage therapy against <i>Klebsiella pneumoniae</i> infections: integrating host-phage immune interactions, therapeutic strategies, and clinical translation. [PDF]

Front Microbiol
Giju JK, Padmakumar S, Jaykumar AP, Babu P, Madhavan A, Nair BG, Kumar GB.   +6 more
europepmc   +1 more source

Calciphylaxis complicated by NDM-1-producing Pseudomonas aeruginosa: first experience with cefepime-zidebactam alongside phage therapy in the USA. [PDF]

Lancet Infect Dis
Ulloa ER, Jaffurs D, Tran MT, Lin C, Tran H, Chan D, Nael A, Nigwekar SU, Nikolich MP, Van Tyne D.   +9 more
europepmc   +1 more source

Phage Therapy at the Crossroads Between Clinical Promise and Regulatory Challenge. [PDF]

Pharmaceuticals (Basel)
Gallina A, Gallina M, Cona A, Vitulo P, Mularoni A, Provenzani A.   +5 more
europepmc   +1 more source

Phage therapy in revision arthroplasty: State of the art and application protocols. [PDF]

Arthroplasty
Wolfgart JM, Schenker H, Gatz M, Migliorini F, Eschweiler J, Langwald S, Horz HP, Eisert A, Schwanz T, Hofmann UK.   +9 more
europepmc   +1 more source

mGem: Immune recognition and clearance of bacteriophages-implications for phage therapy. [PDF]

mBio
Le HT, Ahlenstiel G, Venturini C, Read SA.   +3 more
europepmc   +1 more source

Phages and quorum sensing: findings to consider in phage therapy. [PDF]

Eur J Clin Microbiol Infect Dis
Fernández-Garcia L, Blasco L, Bleriot I, Arman L, Ibarguren-Quiles C, Barrio-Pujante A, de Aledo MG, García-Contreras R, Cantón R, Wood TK, Tomas M.   +10 more
europepmc   +1 more source

Molecular diversity and evolutionary dynamics of phage receptor binding proteins in Staphylococcus aureus: implications for phage therapy and resistance. [PDF]

Sci Rep
VinodKumar CS, Prasad BS, Arunkumar A, Najar IN, Singh A, Emilda JKV, Venkatesh R, Sivaji V, Jayasimha VL, Arakera SB, Kalasuramath S, Ramesh N, Veeraraghavan B.   +12 more
europepmc   +1 more source

Phage therapy for environmental biotechnology applications. [PDF]

Front Microbiol
Singh S, Samson R, Hassard F.
europepmc   +1 more source

Steering the course: targeting and exploiting surface receptors in phage therapy. [PDF]

J Bacteriol
Tran VN, Burrows LL.
europepmc   +1 more source